A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

The emergence of Haemanthus, a company formed by Elizabeth Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and ...

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...

After his job was cut, a CDC scientist volunteered to help Milwaukee respond to the lead crisis in its public schools. For ...

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...

OpenAI on Monday released a large dataset for evaluating how well large language models answer questions related to health ...

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

President Trump confirmed late yesterday that he would revive a “most-favored nation” drug pricing policy, aiming to tie U.S.

Chinese and Chinese-American researchers are reassessing their futures in the U.S., potentially shifting the balance in ...